Theseus Pharmaceuticals Cash Flow Statement

Financials in millions EUR. Fiscal year is March - February.

Millions EUR. Fiscal year is Mar - Feb.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	2016 - 2020
Net Income	243.64	304.43	224.71	165.12	140.69	Upgrade
Depreciation & Amortization	211.65	210.08	229.43	197.02	173.45	Upgrade
Other Amortization	2.77	-	-	-	-	Upgrade
Loss (Gain) From Sale of Assets	-1.35	0.43	3.47	-1.79	1.8	Upgrade
Loss (Gain) on Equity Investments	-0.88	1.14	5.94	1.46	-0.96	Upgrade
Other Operating Activities	6.8	-2.08	22.18	-14.76	3.18	Upgrade
Change in Accounts Receivable	-81.09	-	-	-	-	Upgrade
Change in Inventory	-20.9	-	-	-	-	Upgrade
Change in Other Net Operating Assets	76.21	-23.26	24.2	-19.85	12.41	Upgrade
Operating Cash Flow	436.85	490.73	509.92	327.21	330.57	Upgrade
Operating Cash Flow Growth	-10.98%	-3.76%	55.84%	-1.02%	16.36%	Upgrade
Capital Expenditures	-323.93	-293.48	-261.45	-250.98	-217.5	Upgrade
Sale of Property, Plant & Equipment	18.31	16.14	18.54	12.79	9.46	Upgrade
Cash Acquisitions	-228.68	-35.04	-27.17	-24.06	-5.7	Upgrade
Investing Cash Flow	-534.3	-312.37	-270.08	-262.25	-213.74	Upgrade
Long-Term Debt Issued	236.13	49.28	186.08	107.01	138.89	Upgrade
Long-Term Debt Repaid	-111.86	-174.54	-114.44	-118.83	-164.32	Upgrade
Net Debt Issued (Repaid)	124.27	-125.26	71.64	-11.82	-25.44	Upgrade
Issuance of Common Stock	-	-	-	41.04	4.5	Upgrade
Repurchase of Common Stock	-	-25.29	-2.36	-5.57	-	Upgrade
Common Dividends Paid	-65.05	-48.36	-36.17	-32.29	-24.26	Upgrade
Other Financing Activities	59.89	29.82	-159.35	-27.53	18.25	Upgrade
Financing Cash Flow	119.12	-169.09	-126.23	-36.16	-26.95	Upgrade
Foreign Exchange Rate Adjustments	-3.19	1.35	-3.17	-0.32	-1.21	Upgrade
Net Cash Flow	18.48	10.62	110.45	28.48	88.68	Upgrade
Free Cash Flow	112.91	197.26	248.47	76.23	113.08	Upgrade
Free Cash Flow Growth	-42.76%	-20.61%	225.94%	-32.58%	161.19%	Upgrade
Free Cash Flow Margin	1.79%	3.18%	4.25%	1.50%	2.55%	Upgrade
Free Cash Flow Per Share	3.26	5.70	7.10	2.17	3.31	Upgrade
Levered Free Cash Flow	9.83	125.05	218.04	65.89	103.21	Upgrade
Unlevered Free Cash Flow	17.63	131.25	221.39	67.07	104.77	Upgrade
Change in Net Working Capital	62.68	15.72	-49.66	10.07	-29.95	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.